Skip to main content

Nasdaq Stocks

IFRA's Underlying Holdings Imply 11% Gain Potential

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Peek Under The Hood: FNX Has 10% Upside

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Analysts See 10% Upside For VONV

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

The Math Shows FXD Can Go To $63

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Peek Under The Hood: KBE Has 10% Upside

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

EW Crosses Above Average Analyst Target

2 years 9 months ago
In recent trading, shares of Edwards Lifesciences Corp (Symbol: EW) have crossed above the average analyst 12-month target price of $77.45, changing hands for $78.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Dr. Reddy's Laboratories Reaches Analyst Target Price

2 years 9 months ago
In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $71.67, changing hands for $71.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down

VB's Underlying Holdings Imply 12% Gain Potential

2 years 9 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

ASH Crosses Above Average Analyst Target

2 years 9 months ago
In recent trading, shares of Ashland Inc (Symbol: ASH) have crossed above the average analyst 12-month target price of $90.11, changing hands for $93.62/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

Bull of the Day: Cardinal Health (CAH)

2 years 9 months ago
Cardinal Health CAH is a multinational healthcare services and products company based in the United States. It operates as a crucial player in the pharmaceutical and medical supply chain, providing a range of services to healthcar

Bear of the Day: RH (RH)

2 years 9 months ago
RH RH, also known as Restoration Hardware, is a luxury home furnishings company known for its high-end and curated collections of furniture, lighting, textiles, and décor. RH is well known for its impressive retail locations and c
Checked
27 minutes 13 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed